Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-146,811
Closed -$3.4M 115
2024
Q4
$3.4M Sell
146,811
-4,023
-3% -$116K 0.64% 59
2024
Q3
$5.25M Buy
150,834
+843
+0.6% +$28.8K 0.95% 44
2024
Q2
$4.86M Sell
149,991
-17,365
-10% -$579K 0.98% 45
2024
Q1
$5.69M Buy
167,356
+43,094
+35% +$1.64M 1.13% 39
2023
Q4
$4.89M Buy
124,262
+15,429
+14% +$597K 1.05% 44
2023
Q3
$4.15M Buy
108,833
+98,883
+994% +$4.15M 0.96% 47
2023
Q2
$454K Buy
9,950
+1,048
+12% +$48.8K 0.1% 95
2023
Q1
$399K Sell
8,902
-1,846
-17% -$83.4K 0.09% 100
2022
Q4
$472K Buy
10,748
+5,168
+93% +$233K 0.1% 93
2022
Q3
$234K Buy
+5,580
New +$271K 0.06% 107

Other funds holding BCE

Advocate Group's BCE Position: Q1 2025 in Review

Advocate Group sold out of BCE (BCE) in Q1 2025, closing a stake of 146,811 shares — an estimated $3.4M sold.

Advocate Group first reported a position in BCE in Q3 2022 and held it in 10 quarters. The position peaked at $5.69M in Q1 2024. 401 funds tracked by Wall St. Rank hold BCE as of Q1 2025.

  • Advocate Group reported no remaining BCE position as of Q1 2025 after selling out during the quarter.
  • Advocate Group sold 146,811 BCE shares in Q1 2025, an estimated $3.4M.
  • Advocate Group first reported a position in BCE in Q3 2022 and held it in 10 quarters.
  • Advocate Group's BCE position peaked at $5.69M in Q1 2024.
  • 401 funds tracked by Wall St. Rank held BCE as of Q1 2025.

Based on Advocate Group's 13F filing for Q1 2025, filed 22 Apr 2025.